Cargando…
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness
Despite recent approval of targeted drugs for acute myeloid leukemia (AML) therapy, chemotherapy with cytosine arabinoside and anthracyclines remains an important pillar of treatment. Both primary and secondary resistance are frequent and associated with poor survival, yet the underlying molecular m...
Autores principales: | Grandits, Alexander Michael, Nguyen, Chi Huu, Schlerka, Angela, Hackl, Hubert, Sill, Heinz, Etzler, Julia, Heyes, Elizabeth, Stoiber, Dagmar, Grebien, Florian, Heller, Gerwin, Wieser, Rotraud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478650/ https://www.ncbi.nlm.nih.gov/pubmed/33782537 http://dx.doi.org/10.1038/s41375-021-01224-2 |
Ejemplares similares
-
CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
por: Gluexam, Tobias, et al.
Publicado: (2019) -
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
por: Nguyen, Chi Huu, et al.
Publicado: (2019) -
Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A
por: Grandits, Alexander M., et al.
Publicado: (2021) -
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia
por: Nguyen, Chi Huu, et al.
Publicado: (2019) -
Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells
por: Nguyen, Chi Huu, et al.
Publicado: (2020)